ORIGINAL RESEARCH article
Front. Psychiatry
Sec. Aging Psychiatry
Volume 16 - 2025 | doi: 10.3389/fpsyt.2025.1635817
This article is part of the Research TopicThe Role of Neuropsychiatry in Neurodegenerative DisordersView all 8 articles
Association Between Inflammatory Markers (SII and SIRI) and Anxiety Levels in Parkinson's Disease
Provisionally accepted- Chengdu Second People's Hospital, Chengdu, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder frequently associated with anxiety, which can significantly impair patients' quality of life. Emerging evidence suggests that systemic inflammation may contribute to the development of anxiety in PD. The Systemic Immune-Inflammation Index (SII) and Systemic Inflammation Response Index (SIRI) are composite biomarkers reflecting systemic inflammatory status. However, the relationship between these inflammatory markers and anxiety levels in PD patients remains to be elucidated.To investigate the association between SII and SIRI and anxiety levels in PD patients.This cross-sectional study utilized data from the PPMI database, including 1,289 PD patients. Anxiety levels were assessed using the State-Trait Anxiety Inventory (STAI), with separate evaluations for state and trait anxiety. Linear regression analyses were performed to assess the associations between SII, SIRI, and anxiety levels. Curve fitting analysis was conducted to explore potential non-linear relationships, and sensitivity and subgroup analyses were performed to verify the robustness of the results.Results: Linear regression analyses showed significant positive associations between SII and overall STAI scores [β = 0.34 (95% CI 0.07 -0.6), p = 0.014], STAI-state [β = 0.21 (95% CI 0.06 -0.36), p = 0.005], and a non-significant association with STAItrait [β = 0.13 (95% CI -0.01 -0.26), p = 0.073]. SIRI was significantly associated with overall STAI scores [β = 0.16 (95% CI 0.04 -0.27), p = 0.008], STAI-state [β = 0.1 (95% CI 0.04 -0.17), p = 0.002], and a non-significant association with STAI-trait [β = 0.06 (95% CI 0 -0.12), p = 0.068]. Curve fitting analysis revealed no significant non-linear relationships between SII/SIRI and anxiety levels, indicating a linear positive correlation. Sensitivity and subgroup analyses confirmed the robustness of these findings.Our study demonstrates a significant positive linear association between SII and SIRI and anxiety levels, particularly state anxiety, in PD patients. These findings suggest that systemic inflammation may play a role in the development of anxiety in PD and highlight the potential utility of SII and SIRI as biomarkers for anxiety in this population. Future longitudinal studies are warranted to explore the causal relationship and potential therapeutic implications.
Keywords: Parkinson's disease, Anxiety, Systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), Inflammation, Cross-sectional study
Received: 27 May 2025; Accepted: 20 Aug 2025.
Copyright: © 2025 Zhou, Zeng, Liu, Pang and Gong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Wen Zhou, Chengdu Second People's Hospital, Chengdu, China
Liang Gong, Chengdu Second People's Hospital, Chengdu, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.